PedAM
Pediatric Disease Annotations & Medicines
| Disease | open-angle glaucoma |
| Symptom | C0021888|intraocular pressure |
| Sentences | 47 |
| PubMedID- 21873661 | A population-based assessment of 24-hour intraocular pressure among subjects with primary open-angle glaucoma: the handan eye study. |
| PubMedID- 23483493 | Purpose: to investigate relationships between blood pressure (bp), ocular perfusion pressure (opp), and intraocular pressure (iop) in patients with open-angle glaucoma (oag) of different body mass index (bmi) classes. |
| PubMedID- 25897195 | It is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.1 the side effects of topical dorzolamide hydrochloride, such as conjunctivitis, eyelid edema, and eye lid irritation, are well known.2 however, allergic contact dermatitis due to dorzolamide is rare, although it has been commonly used worldwide in patients with glaucoma. |
| PubMedID- 25639001 | Methods: a total of 52 eyes from 52 open-angle glaucoma (oag) patients, with elevated intraocular pressure (lop), were included in this cross-sectional study. |
| PubMedID- 24735011 | Main outcome measures: the risk factors for open-angle glaucoma with normal baseline intraocular pressure were analyzed using univariate and multivariate comparisons. |
| PubMedID- 21437058 | Bimatoprost ophthalmic solution 0.03% (lumigan®; allergan, inc.) was initially developed as an ocular antihypertensive and, in 2001, was approved for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension.19 as a glaucoma treatment, bimatoprost ophthalmic solution 0.03% is administered as a drop into the affected eye once daily. |
| PubMedID- 23218823 | Purpose: to compare the change in lamina cribrosa (lc) displacement in response to intraocular pressure (iop) lowering in patients with open-angle glaucoma (oag) using spectral-domain optical coherence tomography (sd-oct). |
| PubMedID- 22320418 | Purpose: to compare the efficacy and safety of dorzolamide hydrochloride 2%/timolol maleate 0.5% fixed combination (dtfc) with latanoprost 0.005%/timolol maleate 0.5% fixed combination (ltfc) on diurnal intraocular pressure (iop) in patients with primary open-angle glaucoma. |
| PubMedID- 25996599 | in addition, odh occurs up to 4 times more frequently in normal-tension glaucoma (ntg) than in primary open-angle glaucoma (poag) patients with baseline intraocular pressure (iop) of more than 21 mmhg. |
| PubMedID- 24558609 | To evaluate the short-term effect of standard automated perimetry (sap) testing on intraocular pressure (iop) in patients with open-angle glaucoma (oag). |
| PubMedID- 20390038 | Clinical studies have demonstrated its efficacy at decreasing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. |
| PubMedID- 22256559 | Purpose: the aim of the study was to evaluate the role of two potent and long-acting vasoconstrictors: endothelin-1 (et-1) and neuropetide y (npy) in the pathogenesis of glaucoma by: 1) measurement of plasma et-1 and npy concentrations in primary open-angle glaucoma (poag) patients with high intraocular pressure (htg patients) and with normal intraocular pressure (ntg patients) at baseline and following peripheral exposure to cold (cold-pressor test), 2) assessment whether changes, if any, in the plasma concentrations of both peptides following the cold-pressor test correlate with visual field defects. |
| PubMedID- 23111175 | The effect of lateral decubitus position on intraocular pressure in patients with untreated open-angle glaucoma. |
| PubMedID- 25088623 | The elevated intraocular pressure (iop) of primary open-angle glaucoma is caused by impaired outflow of aqueous humor through the trabecular meshwork. |
| PubMedID- 24771165 | Results: two patients with primary open-angle glaucoma underwent canaloplasty because of medically uncontrolled intraocular pressure (iop). |
| PubMedID- 24204049 | Changes in the lamina and prelamina after intraocular pressure reduction in patients with primary open-angle glaucoma and acute primary angle-closure. |
| PubMedID- 25213118 | The intraocular pressure (iop) reduction with taf/tim in open-angle glaucoma and ocular hypertension is similar to that of other prostaglandin-timolol fixed-combination products. |
| PubMedID- 23055676 | The inclusion criteria were: primary open-angle glaucoma with intraocular pressure that was considered unsatisfactory despite maximum tolerable medication; no history of operative procedures including filtering, cataract, and refractive surgery, but excluding laser trabeculoplasty, in either eye before the study; the absence of other coexisting ocular or systemic disorders, including cataract that may affect visual field examination; preoperative best corrected visual acuity at least 40/50; and two or more reproducible visual field examination results using the swedish interactive threshold algorithm standard 24-2 program of the humphrey visual field analyzer (carl zeiss meditec, dublin, ca) before trabeculectomy. |
| PubMedID- 23018347 | Non-penetrating deep sclerectomy (npds) is a surgical procedure for lowering intraocular pressure in patients with uncontrolled open-angle glaucoma. |
| PubMedID- 21048514 | Aim: to evaluate the efficacy and tolerability of flunarizine, a nonselective calcium channel blocker, on intraocular pressure (iop) in patients with open-angle glaucoma (oag) or ocular hypertension (oh). |
| PubMedID- 23111749 | Background: we evaluated the relation of systemic blood pressure with intraday variations in ocular perfusion pressure and intraocular pressure in patients with primary open-angle glaucoma in a telemedical home monitoring scenario. |
| PubMedID- 23009074 | Goldmann applanation tonometry compared with corneal-compensated intraocular pressure in the evaluation of primary open-angle glaucoma. |
| PubMedID- 22167545 | Purpose: to assess the retrobulbar hemodynamic parameters in the ophthalmic artery (oa), central retinal artery (cra), and short posterior ciliary arteries (pca) after decreasing elevated intraocular pressure (iop) in patients with open-angle glaucoma (oag) by using color doppler imaging. |
| PubMedID- 20730536 | Bimatoprost is a synthetic prostamide, or prostaglandin ethanolamide, analog approved in 2001 for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension (lumigan package insert, allergan, inc., 2006). |
| PubMedID- 26107474 | The effects of fixed combination of bimatoprost-timolol and travoprost-timolol on intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension, previously on nonfixed combination of latanoprost and timolol. |
| PubMedID- 21849211 | Among the remaining studies, level ii evidence supports the efficacy of selective laser trabeculoplasty for lowering intraocular pressure for patients with open-angle glaucoma. |
| PubMedID- 24689838 | Conclusions: uc(3) procedure seems to be an effective and well tolerated method to reduce intraocular pressure in patients with primary open-angle glaucoma. |
| PubMedID- 21127505 | Purpose: to investigate factors associated with changes in optic nerve head (onh) topography after acute intraocular pressure (iop) reduction in patients with primary open-angle glaucoma (poag). |
| PubMedID- 21995983 | Objective: selective laser trabeculoplasty (slt) and argon laser trabeculoplasty (alt) are used to lower intraocular pressure (iop) in patients with open-angle glaucoma (oag). |
| PubMedID- 20944938 | In bed and darkness for the diagnosis and intraocular pressure control of primary open-angle glaucoma. |
| PubMedID- 21543995 | Purpose: to compare the longitudinal change of frequency doubling technology (fdt) perimetry and standard automated perimetry (sap) results in sap-normal hemifield in open-angle glaucoma (oag) eyes with low-to-normal intraocular pressure (iop). |
| PubMedID- 23835670 | Purpose: to evaluate the efficacy of selective laser trabeculoplasty (slt) versus argon laser trabeculoplasty (alt) in lowering the intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension secondary to pseudoexfoliation. |
| PubMedID- 24059679 | Of 1,589 eligible people, we detected 284 (17.9%) cases of glaucoma overall, including 36 (2.3%) cases of primary open-angle glaucoma with intraocular pressure levels greater than 21 mmhg, 226 (14.2%) cases of normal-tension glaucoma and 25 (1.6%) cases of primary angle-closure glaucoma. |
| PubMedID- 22171066 | Primary open-angle glaucoma is associated with elevated intraocular pressure, which in turn is believed to result from impaired outflow of aqueous humour. |
| PubMedID- 24939513 | Purpose: to evaluate the long-term reproducibility of diurnal intraocular pressure (iop) patterns in patients with primary open-angle glaucoma (poag). |
| PubMedID- 22613602 | Effect of high myopia on 24-hour intraocular pressure in patients with primary open-angle glaucoma. |
| PubMedID- 24232829 | Design, setting, and participants: prospective clinical cohort study at kumamoto university hospital, kumamoto, japan, among patients 55 years or older having open-angle glaucoma with intraocular pressure (iop) of 22 mm hg or higher, including 39 phakic eyes (phakic group) and 25 pseudophakic eyes after phacoemulsification (pseudophakic group). |
| PubMedID- 21905603 | The study was aimed at evaluating the efficacy of diode laser trabeculoplsaty in lowering intraocular pressure in patients with both primary open-angle glaucoma and exfoliation glaucoma by using different size of laser spot. |
| PubMedID- 21104187 | Background: to determine if asymmetrical postural change-induced elevations in intraocular pressure (iop) in eyes of patients with primary open-angle glaucoma (poag) were associated with asymmetries in functional and structural damage. |
| PubMedID- 25732405 | Brinzolamide 1 %/brimonidine 0.2 % ophthalmic suspension (simbrinza((r))) is a fixed-combination of a carbonic anhydrase inhibitor and an alpha2-adrenergic receptor agonist that is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension in both the usa and eu (with the eu indication restricted to patients for whom monotherapy provides insufficient iop reduction). |
| PubMedID- 21468336 | Several different classes of drugs are available for the reduction of elevated intraocular pressure (iop) associated with open-angle glaucoma or ocular hypertension, including β-blockers, carbonic anhydrase inhibitors (cais), prostaglandin analogs (pgas), and α-2 agonists. |
| PubMedID- 24286181 | Effects of several anti-glaucoma medications on the circadian intraocular pressure fluctuations in patients with primary open-angle glaucoma. |
| PubMedID- 26286384 | Both slt and topical medication demonstrate similar success rates and effectiveness in lowering intraocular pressure in patients with open-angle glaucoma. |
| PubMedID- 22668981 | intraocular pressure fluctuation in patients with primary open-angle glaucoma combined with high myopia. |
| PubMedID- 24481483 | Objective to assess the effectiveness of intraocular pressure (iop)-lowering medications in patients with open-angle glaucoma. |
| PubMedID- 24027965 | The effect of crystalline lens extraction on intraocular pressure in patients with primary open-angle glaucoma. |
| PubMedID- 20590394 | Primary open-angle glaucoma without satisfying intraocular pressure (iop) control (>or=21 mmhg) despite maximally tolerated medications or with progression of visual field and cataract was the indication for surgery. |
Page: 1